1,160
Participants
Start Date
January 1, 2018
Primary Completion Date
July 31, 2020
Study Completion Date
December 31, 2020
Collection of stool samples
Patients receiving routine treatment (immunotherapy using anti-PD1 / anti-PDL1 and / or anti CTLA4 antibodies), financed by the Polish National Health Fund (NFZ).
RECRUITING
The Institute of Bioorganic Chemistry, Polish Academy of Sciences, Poznan
Lead Sponsor
The Institute of Bioorganic Chemistry, Polish Academy of Sciences
UNKNOWN
National Center for Research and Development, Poland
OTHER
Ardigen
INDUSTRY